- Exact Sciences Corp., headquartered in Madison, Wisconsin, is a leading provider of cancer screening and diagnostic tests, generating $3.25 billion in revenue for the full year 2025, with significant contributions from its Screening and Precision Oncology segments.
- In March 2026, Exact Sciences was acquired by Abbott, enhancing Abbott's capabilities in the cancer screening and diagnostics market and allowing for the expansion of access to early cancer detection tools.
- The company has established partnerships and received support for its multi-cancer early detection tests, particularly following the passage of the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act in February 2026, which aims to improve Medicare coverage for such tests.
- Exact Sciences' ideal buyers include healthcare providers and systems looking to enhance cancer screening capabilities, as they address the critical need for early detection of cancers that currently lack recommended screening protocols.
Exact Sciences employs a diverse workforce across 18 departments, with Operations leading at 839 employees, followed by Community and Social Services with 490. Information Technology also plays a significant role, contributing 310 staff members. The balance among these departments indicates a strong emphasis on operational efficiency and community engagement, while technical support remains robust.
The company's workforce is primarily concentrated in Madison, WI, which houses 1,125 employees, followed by Redwood City, CA, with 60, and San Diego, CA, at 56. The presence of 1,725 employees in 'Other' locations suggests a distributed workforce model, enhancing operational flexibility. This geographic distribution underscores a strategic focus on key markets while maintaining a significant base in Wisconsin.
